Početna › Rak endometrija
Kliničke studije za Rak endometrija koje traže sudionike u SAD-u
168 studija za Rak endometrija traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- Houston, TX68 studija
- New York City, NY52 studija
- Boston, MA50 studija
- Arlington, VA39 studija
- Nashville, TN38 studija
- Los Angeles, CA34 studija
- St. Louis, MO29 studija
- Philadelphia, PA28 studija
- San Antonio, TX27 studija
- Queens, NY25 studija
- Columbus, OH25 studija
- Chicago, IL25 studija
- Oklahoma City, OK25 studija
- Dallas, TX24 studija
- Portland, OR24 studija
- Pittsburgh, PA23 studija
- Detroit, MI21 studija
- Cleveland, OH20 studija
- Rochester, MN20 studija
- Edison, NJ19 studija
- Washington, DC18 studija
- Minneapolis, MN18 studija
- Grand Rapids, MI18 studija
- Orlando, FL17 studija
- Atlanta, GA17 studija
- Seattle, WA17 studija
- Baldwin Park, CA17 studija
- Durham, NC16 studija
- Miami, FL16 studija
- Birmingham, AL16 studija
- San Diego, CA16 studija
- Austin, TX15 studija
- Denver, CO15 studija
- Tampa, FL15 studija
- Sarasota, FL15 studija
- New Haven, CT14 studija
- Providence, RI14 studija
- Salt Lake City, UT14 studija
- Indianapolis, IN14 studija
- Aurora, CO14 studija
Po državama
- Alabama19 studija
- Aljaska4 studija
- Arizona22 studija
- Arkansas12 studija
- Colorado30 studija
- Connecticut20 studija
- Delaware4 studija
- Distrikt Columbia10 studija
- Florida65 studija
- Georgia24 studija
- Havaji3 studija
- Idaho4 studija
- Illinois38 studija
- Indiana19 studija
- Iowa10 studija
- Kalifornija73 studija
- Kansas5 studija
- Kentucky10 studija
- Louisiana15 studija
- Maine7 studija
- Maryland22 studija
- Massachusetts53 studija
- Michigan43 studija
- Minnesota39 studija
- Mississippi5 studija
- Missouri31 studija
- Montana5 studija
- Nebraska10 studija
- Nevada8 studija
- New Jersey32 studija
- New Mexico13 studija
- New York69 studija
- North Carolina31 studija
- North Dakota6 studija
- Ohio50 studija
- Oklahoma28 studija
- Oregon27 studija
- Pennsylvania42 studija
- Rhode Island14 studija
- South Carolina9 studija
- South Dakota11 studija
- Tennessee41 studija
- Texas91 studija
- Utah25 studija
- Virginia51 studija
- Washington20 studija
- West Virginia4 studija
- Wisconsin24 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
Tirzepatide in Obesity-Driven Endometrial Cancer
U tijeku regrutacijaRana faza 1
Od 18 godina i više · Žene · Ažurirano 2. lis 2026. · NCT07065552Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
U tijeku regrutacijaFaza 2
Sve dobne skupine · Oba spola · Ažurirano 2. lis 2026. · NCT05564377Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
U tijeku regrutacijaFaza 1
Od 18 godina i više · Žene · Ažurirano 2. lis 2026. · NCT05950464The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07059884A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
U tijeku regrutacijaFaza 3
Od 18 godina i više · Žene · Ažurirano 2. lis 2026. · NCT07286331A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06270706Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
U tijeku regrutacijaFaza 3
Od 18 godina i više · Žene · Ažurirano 2. lis 2026. · NCT07198074A Phase 1 Study of the Safety and Tolerability of CTX-10726
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07419841Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
U tijeku regrutacijaFaza 2
Od 18 do 72 godina · Oba spola · Ažurirano 2. lis 2026. · NCT01174121A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
U tijeku regrutacijaFaza 1
Od 19 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06586957A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07189871The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07285044A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07814248Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Žene · Ažurirano 29. ruj 2026. · NCT05051722Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
U tijeku regrutacijaFaza 2
Od 18 godina i više · Žene · Ažurirano 28. ruj 2026. · NCT05112601Study of AVZO-021 in Patients With Advanced Solid Tumors
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT05867251DESTINY-PANTUMOUR04
U tijeku regrutacijaOpažajna studija
Od 18 do 130 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07124000Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06218914ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
U tijeku regrutacija
Od 18 godina i više · Žene · Ažurirano 25. ruj 2026. · NCT07270666Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Žene · Ažurirano 25. ruj 2026. · NCT03564340Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
U tijeku regrutacijaFaza 2
Od 18 godina i više · Žene · Ažurirano 24. ruj 2026. · NCT07594015A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Žene · Ažurirano 24. ruj 2026. · NCT04590326Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.